First detection of TR46/Y121F/T289A and TR34/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environment
- PMID: 24936595
- PMCID: PMC4135837
- DOI: 10.1128/AAC.02855-14
First detection of TR46/Y121F/T289A and TR34/L98H alterations in Aspergillus fumigatus isolates from azole-naive patients in Denmark despite negative findings in the environment
Abstract
Azole-resistant Aspergillus fumigatus harboring the TR34/L98H or TR46/Y121F/T289A alterations is increasingly found in Europe and Asia. Here, we present the first clinical cases of TR46/Y121/T289A and three cases of TR34/L98H outside the cystic fibrosis (CF) population in Denmark and the results of environmental surveys. Four patients (2012 to 2014) with 11 A. fumigatus and 4 Rhizomucor pusillus isolates and 239 soil samples (spring 2010 and autumn 2013, respectively) with a total of 113 A. fumigatus isolates were examined. Aspergillus isolates were screened for azole resistance using azole-containing agar. Confirmatory susceptibility testing was done using the EUCAST microbroth dilution EDEF 9.1 reference method. For relevant A. fumigatus isolates, CYP51A sequencing and microsatellite genotyping were performed. Three patients harbored TR34/L98H isolates. Two were azole naive at the time of acquisition and two were coinfected with wild-type A. fumigatus or R. pusillus isolates, complicating and delaying diagnosis. The TR46/Y121F/T289A strain was isolated in 2014 from a lung transplant patient. Genotyping indicated that susceptible and resistant Aspergillus isolates were unrelated and that no transmission between patients occurred. Azole resistance was not detected in any of the 113 soil isolates. TR34/L98H and TR46/Y121F/T289A alterations appear to be emerging in the clinical setting in Denmark and now involve azole-naive patients. Two recent soil-sampling surveys in Denmark were unable to indicate any increased prevalence of azole-resistant A. fumigatus in the environment. These findings further support the demand for real-time susceptibility testing of all clinically relevant isolates and for studies investigating the seasonal variation and ecological niches for azole-resistant environmental A. fumigatus.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.
Similar articles
-
First azole-resistant Aspergillus fumigatus isolates with the environmental TR46 /Y121F/T289A mutation in Iran.Mycoses. 2020 May;63(5):430-436. doi: 10.1111/myc.13064. Epub 2020 Mar 13. Mycoses. 2020. PMID: 32056319 Free PMC article.
-
Quantitative Analysis of Single-Nucleotide Polymorphism for Rapid Detection of TR34/L98H- and TR46/Y121F/T289A-Positive Aspergillus fumigatus Isolates Obtained from Patients in Iran from 2010 to 2014.Antimicrob Agents Chemother. 2015 Nov 2;60(1):387-92. doi: 10.1128/AAC.02326-15. Print 2016 Jan. Antimicrob Agents Chemother. 2015. PMID: 26525787 Free PMC article.
-
Azole-resistant Aspergillus fumigatus in Denmark: a laboratory-based study on resistance mechanisms and genotypes.Clin Microbiol Infect. 2016 Jun;22(6):570.e1-9. doi: 10.1016/j.cmi.2016.04.001. Epub 2016 Apr 16. Clin Microbiol Infect. 2016. PMID: 27091095
-
Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.Dan Med J. 2016 Oct;63(10):B5288. Dan Med J. 2016. PMID: 27697142 Review.
-
[Azole resistance with environmental origin: What alternatives for the future?].J Mycol Med. 2015 Dec;25(4):249-56. doi: 10.1016/j.mycmed.2015.10.008. Epub 2015 Nov 27. J Mycol Med. 2015. PMID: 26631951 Review. French.
Cited by
-
Genetic Diversity and Dispersal of Aspergillus fumigatus in Arctic Soils.Genes (Basel). 2021 Dec 22;13(1):19. doi: 10.3390/genes13010019. Genes (Basel). 2021. PMID: 35052359 Free PMC article.
-
Fungicide effects on human fungal pathogens: Cross-resistance to medical drugs and beyond.PLoS Pathog. 2021 Dec 9;17(12):e1010073. doi: 10.1371/journal.ppat.1010073. eCollection 2021 Dec. PLoS Pathog. 2021. PMID: 34882756 Free PMC article. Review.
-
First azole-resistant Aspergillus fumigatus isolates with the environmental TR46 /Y121F/T289A mutation in Iran.Mycoses. 2020 May;63(5):430-436. doi: 10.1111/myc.13064. Epub 2020 Mar 13. Mycoses. 2020. PMID: 32056319 Free PMC article.
-
Emerging Fungal Threats in Cystic Fibrosis.Mycopathologia. 2021 Oct;186(5):639-653. doi: 10.1007/s11046-021-00574-w. Epub 2021 Jul 28. Mycopathologia. 2021. PMID: 34319568 Review.
-
Evaluation of MIC Strip Isavuconazole Test for Susceptibility Testing of Wild-Type and Non-Wild-Type Aspergillus fumigatus Isolates.Antimicrob Agents Chemother. 2016 Dec 27;61(1):e01659-16. doi: 10.1128/AAC.01659-16. Print 2017 Jan. Antimicrob Agents Chemother. 2016. PMID: 27799223 Free PMC article.
References
-
- Camps SMT, van der Linden JWM, Li Y, Kuijper EJ, van Dissel JT, Verweij PE, Melchers WJ. 2012. Rapid induction of multiple resistance mechanisms in Aspergillus fumigatus during azole therapy: a case study and review of the literature. Antimicrob. Agents Chemother. 56:10–16. 10.1128/AAC.05088-11 - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources